Are phosphodiesterase type 5 inhibitors associated with increased risk of melanoma?
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference20 articles.
1. An update on new oral PDE5 inhibitors for the treatment of erectile dysfunction;Palit;Nat Rev Urol,2010
2. Viagra deafness—sensorineural hearing loss and phosphodiesterase-5 inhibitors;Khan;Laryngoscope,2011
3. Are phosphodiesterase type 5 inhibitors associated with vision-threatening adverse events? A critical analysis and review of the literature;Azzouni;J Sex Med,2011
4. Oncogenic BRAF induces melanoma cell invasion by downregulating the cGMP-specific phosphodiesterase PDE5A;Arozarena;Cancer Cell,2011
5. Sildenafil use and increased risk of incident melanoma in US men: a prospective cohort study;Li;JAMA Int Med,2014
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. An overview of conventional and investigational phosphodiesterase 5 inhibitors for treating erectile dysfunction and other conditions;Expert Opinion on Investigational Drugs;2024-08-11
2. Safety profile and signal detection of phosphodiesterase type 5 inhibitors for erectile dysfunction: a Food and Drug Administration Adverse Event Reporting System analysis;Sexual Medicine;2023-10-01
3. How do phosphodiesterase-5 inhibitors affect cancer? A focus on glioblastoma multiforme;Pharmacological Reports;2022-01-20
4. Discovery of Novel Agents on Spindle Assembly Checkpoint to Sensitize Vinorelbine-Induced Mitotic Cell Death against Human Non-Small Cell Lung Cancers;International Journal of Molecular Sciences;2020-08-05
5. Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer’s disease;Biochemical Pharmacology;2020-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3